Gregory N. Fuller

Active 1978–2025

144
Papers
26,542
Citations
95
h-index
143
i10-index

Citations

Citations per year for Gregory N. Fuller1982: 1 citations1984: 1 citations1986: 1 citations1990: 3 citations1991: 3 citations1992: 8 citations1993: 10 citations1994: 16 citations1995: 13 citations1996: 13 citations1997: 27 citations1998: 30 citations1999: 44 citations2000: 40 citations2001: 79 citations2002: 87 citations2003: 129 citations2004: 155 citations2005: 193 citations2006: 166 citations2007: 181 citations2008: 192 citations2009: 205 citations2010: 191 citations2011: 208 citations2012: 176 citations2013: 174 citations2014: 216 citations2015: 214 citations2016: 231 citations2017: 292 citations2018: 274 citations2019: 807 citations2020: 1,135 citations2021: 1,156 citations2022: 842 citations2023: 658 citations2024: 835 citations2025: 392 citations2026: 14 citations1983: no citations, so this year is not shown1985: no citations, so this year is not shown1987–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,588 citing papers, 30.6% of this breakdownChina: 1,563 citing papers, 13.3% of this breakdownGermany: 719 citing papers, 6.1% of this breakdownItaly: 523 citing papers, 4.5% of this breakdownUnited Kingdom: 513 citing papers, 4.4% of this breakdownCanada: 391 citing papers, 3.3% of this breakdownFrance: 362 citing papers, 3.1% of this breakdownJapan: 346 citing papers, 2.9% of this breakdownNetherlands: 293 citing papers, 2.5% of this breakdownSpain: 279 citing papers, 2.4% of this breakdownSwitzerland: 247 citing papers, 2.1% of this breakdownAustralia: 231 citing papers, 2% of this breakdown
0%30.6%Other 22.8%

Fields

  • Medicine54.9%
  • Biochemistry, Genetics and Molecular Biology32%
  • Immunology and Microbiology6.5%
  • Neuroscience3%
  • Engineering1%
  • Computer Science0.8%
  • Other1.8%

Topics

  • Glioma Diagnosis and Treatment13%
  • Immune cells in cancer3.5%
  • MicroRNA in disease regulation3%
  • Cancer Immunotherapy and Biomarkers2.4%
  • Brain Metastases and Treatment2.2%
  • Cancer, Hypoxia, and Metabolism2.2%
  • Other73.7%

Coauthors

All papers

Open in search
  1. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jill S. Barnholtz‐Sloan, Siyuan Zheng, Kenneth R. Hess, Ganesh Rao, Matthew Meyerson, Rameen Beroukhim, Lee Cooper, Rehan Akbani, Margaret Wrensch, David Haussler, Kenneth D. Aldape, Peter W. Laird, David H. Gutmann, Houtan Noushmehr, Antonio Iavarone, Roel G.W. Verhaak, Samreen Anjum, Harindra Arachchi, J. Todd Auman, Miruna Balasundaram, Saianand Balu, Gene H. Barnett, Stephen Baylin, Sue Bell, Christopher C. Benz, Natalie Bir, Keith L. Black, Tom Bodenheimer, Lori Boice, Moiz S. Bootwalla, Jay Bowen, Christopher A. Bristow, Yaron S.N. Butterfield, Qingrong Chen, Lynda Chin, Juok Cho, Eric Chuah, Sudha Chudamani, Simon G. Coetzee, Mark L. Cohen, Howard Colman, Marta Couce, Fulvio D’Angelo, Tanja M. Davidsen, Amy Davis, John A. Demchok, Karen Devine, Li Ding, Rebecca Duell, J. Bradley Elder, Jennifer Eschbacher, Ashley Fehrenbach, Martin L. Ferguson, Scott Frazer, Gregory N. Fuller, Jordonna Fulop, Stacey Gabriel, Luciano Garofano, Julie M. Gastier-Foster, Nils Gehlenborg, Mark Gerken, Gad Getz, Caterina Giannini, William J. Gibson, Angela Hadjipanayis, D. Neil Hayes, David I. Heiman, Beth Hermes, Joe Hilty, Katherine A. Hoadley and 108 more - Cell 2016 cited by 2,375

  2. Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2018 cited by 708

  3. Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2018 cited by 404

  4. Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elena Bargagli, Qasim Bhorat, Paul Bird, Przemysław Borowy, Céline Boutry, Carles Brotons Cuixart, David Browder, Judith C. Brown, Erik Buntinx, Donald P. Cameron, Laura Cámpora, Cyrille Cartier, Kenneth Chinsky, Melissa Choi, Eun Ju Choo, Delphine Collete, Maria Corral Carrillo, Susanna Cuadripani, Matthew Davis, Magali de Heusch, Ferdinandus de Looze, Marc De Meulemeester, Ferdinando De Negri, Nathalie De Schrevel, David DeAtkine, Viktoriya Dedkova, Peter Dzongowski, Tamara Eckermann, Brandon Essink, Karen Faulkner, Murdo Ferguson, Gregory N. Fuller, Isabel Maria Galan Melendez, Ivan Gentile, Wayne Ghesquière, Doria Grimard, Scott A. Halperin, Amardeep Heer, Laura Helman, Andre Hotermans, Tomáš Jelı́nek, Jackie Kamerbeek, Hyo Youl Kim, Murray Kimmel, Mark Koch, Satu Kokko, Susanna Koski, Shady Kotb, Antonio Lalueza, Jin Soo Lee, Muriel Lins, Johannes Lombaard, Akbar Mahomed, Mario Malerba, Céline Maréchal, Sandie Marion, Jean‐Benoît Martinot, Cristina Masuet‐Aumatell, Damien McNally, Carlos Eduardo Medina Pech, J M Gonzalez Galvan, Lise Mercati, Narcisa Mesaros, Dieter Mesotten, Essack Mitha, Kathryn Mngadi, Beate Moeckesch, Barnaby Montgomery, Linda Murray, Rhiannon Nally and 55 more - Clinical Infectious Diseases 2024 cited by 162

  5. PD-L1 expression and prognostic impact in glioblastoma

    Authors: , , , , , , , , , , , , , , , , , - Neuro-Oncology 2015 cited by 614

  6. cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas

    Authors: , , , , , , , , , , , , , , , , , , , - Acta Neuropathologica 2020 cited by 530

  7. Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clark C. Chen, Changiz Geula, Raghu Kalluri, Tomasz Żal, Amy B. Heimberger - OncoImmunology 2017 cited by 365

  8. Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - JCI Insight 2016 cited by 454

  9. Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2019 cited by 166

  10. cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Weller, Valerie A. White, David W. Ellison - Brain Pathology 2020 cited by 534

  11. Neutrophils Promote the Malignant Glioma Phenotype through S100A4

    Authors: , , , , , , - Clinical Cancer Research 2013 cited by 283

  12. Anti–PD-1 Induces M1 Polarization in the Glioma Microenvironment and Exerts Therapeutic Efficacy in the Absence of CD8 Cytotoxic T Cells

    Authors: , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 cited by 118

  13. A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma

    Authors: , , , , , , , , , , , , , , , , , , , - CNS Oncology 2022 cited by 76

  14. Respiratory Syncytial Virus Prefusion F Protein Vaccine Is Efficacious in Older Adults With Underlying Medical Conditions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Donald P. Cameron, Laura Cámpora, Kenneth Chinsky, Melissa Choi, Eun Ju Choo, Delphine Collete, Maria Corral Carrillo, Matthew Davis, Magali de Heusch, Ferdinandus de Looze, Marc De Meulemeester, Ferdinando De Negri, Nathalie De Schrevel, David DeAtkine, Viktoriya Dedkova, Dominique Descamps, Nancy Dezutter, Peter Dzongowski, Tamara Eckermann, Brandon Essink, Karen Faulkner, Murdo Ferguson, Gregory N. Fuller, Isabel Maria Galan Melendez, Ivan Gentile, Wayne Ghesquière, Doria Grimard, Olivier Gruselle, Scott A. Halperin, Amardeep Heer, Laura Helman, Andre Hotermans, Tomáš Jelı́nek, Jackie M Kamerbeek, Hyo Youl Kim, Murray Kimmel, Mark Koch, Satu Kokko, Susanna Koski, Shady Kotb, Antonio Lalueza, Joanne M. Langley, Jin Soo Lee, Isabel Leroux‐Roels, Muriel Lins, Johannes Lombaard, Akbar Mahomed, Mario Malerba, Céline Maréchal, Federico Martinón‐Torres, Jean‐Benoît Martinot, Cristina Masuet‐Aumatell, Damien McNally, Carlos Eduardo Medina Pech, J M Gonzalez Galvan, Narcisa Mesaros, Dieter Mesotten, Essack Mitha, Kathryn Mngadi, Beate Moeckesch, Barnaby Montgomery, Linda Murray, Rhiannon Nally, Silvia Narejos Pérez, Joseph L. Newberg, Paul Nugent, Dolores Ochoa Mazarro, Harunori Oda, Aurélie Olivier, Maurizio Orso and 50 more - Clinical Infectious Diseases 2023 cited by 52

  15. Preclinical Characterization of the Antiglioma Activity of a Tropism-Enhanced Adenovirus Targeted to the Retinoblastoma Pathway

    Authors: , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2003 cited by 353

  16. Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma

    Authors: , , , , , , , , , , , , , , , , - Nature Communications 2019 cited by 146

  17. Hypoxia Potentiates Glioma-Mediated Immunosuppression

    Authors: , , , , , , , , - PLoS ONE 2011 cited by 221

  18. IGFBP2: integrative hub of developmental and oncogenic signaling network

    Authors: , , , , , - Oncogene 2020 cited by 182

  19. Malignant Gliomas: MR Imaging Spectrum of Radiation Therapy- and Chemotherapy-induced Necrosis of the Brain after Treatment

    Authors: , , , , , , - Radiology 2000 cited by 677

  20. Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lynda Chin, Roeland Verhaak, Ronald A. DePinho - Cell 2016 cited by 276

  21. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice

    Authors: , , , , , - Nature Genetics 2000 cited by 903

  22. International Society of Neuropathology‐Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Brain Pathology 2014 cited by 572

  23. Incidence and Prognostic Impact of FoxP3+ Regulatory T Cells in Human Gliomas

    Authors: , , , , , , , - Clinical Cancer Research 2008 cited by 330

  24. A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models

    Authors: , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2018 cited by 104